. Author manuscript; available in PMC: 2016 Aug 23.

Published in final edited form as: J Clin Exp Neuropsychol. 2014 Oct 29;36(9):956–966. doi: 10.1080/13803395.2014.957167

Table 4.

Predictive Validity of Baseline Treatment Adherence on 12-Month Cognitive Function

	3MS		TMTA		TMTB		CVLT LDFR
	Β	SE b	β	SE b	β	SE b	β	SE b
Block 1
Age	−.06	.04	−.01	.10	−.10	.11	.06	.09
Sex	.00	.78	−.05	1.86	−.02	2.24	−.08	1.67
LVEF	.02	.02	.19^*	.06	−.04	.07	.12	.05
Hypertension	−.01	.80	−.05	1.95	.04	2.33	−.04	1.73
Diabetes	−.06	.77	−.13	1.88	.00	2.24	−.01	1.67
Sleep Apnea	−.01	.86	−.03	2.04	−.06	2.43	−.09	1.84
BDI-II	.07	.06	.11	.14	.11	.17	.04	.13
Anxiety	−.13	1.19	−.22^**	2.82	−.13	3.39	−.06	2.50
Baseline Test Performance^***	.65^**	.07	.56^**	.10	.72^**	.07	.66^**	.08
R²	.50		.47		.57		.46
F	11.69^**		10.30^**		15.44^**		9.79^**
Block 2
Treatment Adherence	.20^*	.03	.06	.08	.06	.10	.19^*	.07
R²	.53		.47		.57		.49
F for ΔR²	6.75^*		.56		.00		6.03^*

Note.

p < 0.05;

^**

p < 0.01;

^***

Baseline test performance of the 12-month dependent variable was entered as a covariate

Abbreviations: 3MS = Modified Mini Mental State Examination; TMTA = Trail Making Test A; TMTB = Trail Making Test B; CVLT = California Verbal Learning Test; LDFR = Long Delay Free Recall; LVEF = Left ventricular ejection fraction